Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure

Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure

Abstract Background Sodium-glucose cotransporter 2 inhibitor (SGLT2i) reduces the risk of the composite renal endpoint and weakens the progressive decline in renal function in patients with chronic heart failure (HF). However, a detailed mechanism of SGLT2i on renal function and outcome remains unin...

Full description

Bibliographic Details
Main Authors: Masaki Nakagaito, Teruhiko Imamura, Shuji Joho, Ryuichi Ushijima, Makiko Nakamura, Koichiro Kinugawa
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Hemodynamics
Congestion
Chronic kidney disease
Online Access:https://doi.org/10.1186/s12872-021-02163-7

Internet

https://doi.org/10.1186/s12872-021-02163-7

Similar Items